Does Rallies show 13F holders for WW?

Yes. Rallies tracks hedge fund and 13F ownership data for WW, including fund names, share counts, latest tracked quarter, and position changes when available.

Is WW research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WW. It does not provide personalized investment advice.

WW (WW International, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

WW International, Inc. Common Stock (WW) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, WW trades at $9.93 with a market cap of $100.29M and a P/E ratio of 1.30. WW moved +6.84% today. Year to date, WW is -69.27%; over the trailing twelve months it is +1717.02%. Its 52-week range spans $0.12 to $46.95. Analyst consensus is neutral with an average price target of $20.00. Rallies surfaces WW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns WW stock?

Hedge funds tracked by Rallies that own WW include Panagora Asset, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for WW International, Inc. Common Stock.

WW Key Metrics

Key financial metrics for WW
Metric	Value
Price	$9.93
Market Cap	$100.29M
P/E Ratio	1.30
EPS	$7.71
Dividend Yield	0.07%
52-Week High	$46.95
52-Week Low	$0.12
Volume	0
Avg Volume	0
Revenue (TTM)	$710.64M
Net Income	$1.06B
Gross Margin	71.84%

Top Hedge Funds Holding WW

Panagora Asset holds 204.33K shares of WW, changed +0.00% as of Dec 31, 2023.
Centerbook Partners holds 19.02K shares of WW, changed -77.03% as of Dec 31, 2025.
Pinebridge Investments holds 17.20K shares of WW, changed +0.00% as of Sep 30, 2023.

Latest WW News

Weight Watchers Reports Q1 Revenue of $168M, Clinical Subscribers Up 46% — May 7, 2026
Weight Watchers Adds $25-Monthly Ozempic Pill to Med+ Diabetes Program — May 1, 2026
Weight Watchers Allocates $25–30M for June 24 Loan Sweep, $10M for Discounted Prepayment — Apr 27, 2026
Weight Watchers Appoints GLP-1 Access Expert Heather Thiltgen to Board — Apr 20, 2026
Weight Watchers Adds FDA-Approved Oral GLP-1 Foundayo for $149 Monthly Med+ Program — Apr 9, 2026

Recent WW Insider Trades

Hawks Carney bought 20.00K (~$455.00K) on Nov 19, 2025.
Hawks Carney bought 9.06K (~$188.46K) on Nov 19, 2025.
Haag Nicole sold 469 (~$14.47K) on Aug 18, 2025.

WW Analyst Consensus

1 analysts cover WW: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $20.00.

Common questions about WW

Who owns WW stock?: Hedge funds tracked by Rallies that own WW include Panagora Asset, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for WW International, Inc. Common Stock.
Does Rallies show 13F holders for WW?: Yes. Rallies tracks hedge fund and 13F ownership data for WW, including fund names, share counts, latest tracked quarter, and position changes when available.
Is WW research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WW. It does not provide personalized investment advice.